LBA56 Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study - Seufferlein, T; Uhl, W; Algül, H (Annals of Oncology, 2021)
et al.